Xtant Medical Secures $9.75 Million Private Investment

Xtant Medical entered into a securities purchase agreement to sell Xtant common stock and warrants to a group of accredited investors led. Gross proceeds are expected to be approximately $9.75 million, before deducting offering expenses.

Net proceeds will support working capital and other general corporate purposes.

Xtant Medical focuses on...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us